Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alternative mechanisms of miR-34a regulation in cancer.
Slabáková E, Culig Z, Remšík J, Souček K. Slabáková E, et al. Among authors: culig z. Cell Death Dis. 2017 Oct 12;8(10):e3100. doi: 10.1038/cddis.2017.495. Cell Death Dis. 2017. PMID: 29022903 Free PMC article. Review.
The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe.
Drápela S, Khirsariya P, van Weerden WM, Fedr R, Suchánková T, Búzová D, Červený J, Hampl A, Puhr M, Watson WR, Culig Z, Krejčí L, Paruch K, Souček K. Drápela S, et al. Among authors: culig z. Mol Oncol. 2020 Oct;14(10):2487-2503. doi: 10.1002/1878-0261.12756. Epub 2020 Jul 16. Mol Oncol. 2020. PMID: 32579780 Free PMC article.
Toll-Like Receptor 3 in Solid Cancer and Therapy Resistance.
Muresan XM, Bouchal J, Culig Z, Souček K. Muresan XM, et al. Among authors: culig z. Cancers (Basel). 2020 Nov 2;12(11):3227. doi: 10.3390/cancers12113227. Cancers (Basel). 2020. PMID: 33147700 Free PMC article. Review.
Toll-Like Receptor 3 Overexpression Induces Invasion of Prostate Cancer Cells, whereas Its Activation Triggers Apoptosis.
Muresan XM, Slabáková E, Procházková J, Drápela S, Fedr R, Pícková M, Vacek O, Víchová R, Suchánková T, Bouchal J, Kürfürstová D, Král M, Hulínová T, Sýkora RP, Študent V, Hejret V, van Weerden WM, Puhr M, Pustka V, Potěšil D, Zdráhal Z, Culig Z, Souček K. Muresan XM, et al. Among authors: culig z. Am J Pathol. 2022 Sep;192(9):1321-1335. doi: 10.1016/j.ajpath.2022.05.009. Epub 2022 Jun 22. Am J Pathol. 2022. PMID: 35750257 Free article.
Editorial: Heterogeneity and plasticity of prostate cancer.
Culig Z, Jolly MK, Souček K. Culig Z, et al. Front Mol Biosci. 2023 Jun 14;10:1228126. doi: 10.3389/fmolb.2023.1228126. eCollection 2023. Front Mol Biosci. 2023. PMID: 37388249 Free PMC article. No abstract available.
Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway.
Steiner H, Godoy-Tundidor S, Rogatsch H, Berger AP, Fuchs D, Comuzzi B, Bartsch G, Hobisch A, Culig Z. Steiner H, et al. Among authors: culig z. Am J Pathol. 2003 Feb;162(2):655-63. doi: 10.1016/S0002-9440(10)63859-X. Am J Pathol. 2003. PMID: 12547723 Free PMC article.
231 results